Abstract
Rifampicin occasionally causes thrombocytopenia when given as part of an intermittent regimen. A case is reported of severe thrombocytopenia developing after one dose of rifampicin, following a 4-month gap in daily therapy. The literature on rifampicin-induced thrombocytopenia is reviewed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Di Berardino L., Perna G., Silvestri L. G. Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment. Am Rev Respir Dis. 1976 Dec;114(6):1189–1190. doi: 10.1164/arrd.1976.114.6.1189. [DOI] [PubMed] [Google Scholar]
- Ferguson G. C. Rifampicin and thrombocytopenia. Br Med J. 1971 Sep 11;3(5775):638–638. doi: 10.1136/bmj.3.5775.638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Girling D. J. Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother. 1977 Mar;3(2):115–132. doi: 10.1093/jac/3.2.115. [DOI] [PubMed] [Google Scholar]
- Pujet J. C., Homberg J. C., Decroix G. Sensitivity to rifampicin: incidence, mechanism, and prevention. Br Med J. 1974 May 25;2(5916):415–418. doi: 10.1136/bmj.2.5916.415. [DOI] [PMC free article] [PubMed] [Google Scholar]